Tekla Life Sciences Stock Analysis

HQL Stock  USD 13.79  0.04  0.29%   
Tekla Life Sciences is fairly valued with Real Value of 13.96 and Hype Value of 13.79. The main objective of Tekla Life stock analysis is to determine its intrinsic value, which is an estimate of what Tekla Life Sciences is worth, separate from its market price. There are two main types of Tekla Life's stock analysis: fundamental analysis and technical analysis.
The Tekla Life stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

Tekla Stock Analysis Notes

About 35.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.86. Some equities with similar Price to Book (P/B) outperform the market in the long run. Tekla Life Sciences last dividend was issued on the 21st of November 2024. Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. Tekla Life operates under Asset Management classification in the United States and is traded on New York Stock Exchange. To learn more about Tekla Life Sciences call the company at 215 405 5700 or check out https://www.teklacap.com/hql.html.

Tekla Life Quarterly Total Revenue

1.03 Million

Tekla Life Sciences Investment Alerts

Tekla Life Sciences generated a negative expected return over the last 90 days
Tekla Life Sciences has high likelihood to experience some financial distress in the next 2 years
Tekla Life Sciences has about 292.4 K in cash with (12.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
On 30th of September 2024 Tekla Life paid $ 0.49 per share dividend to its current shareholders
Latest headline from seekingalpha.com: abrdn Life Sciences Investors declares 0.50 dividend

Tekla Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 377.16 M.

Tekla Profitablity

The company has Net Profit Margin of 1.56 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of (0.32) %, which entails that for every $100 of revenue, it lost $0.32.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.05  0.04 
Return On Capital Employed(0.01)(0.02)
Return On Assets 0.05  0.04 
Return On Equity 0.05  0.04 

Management Efficiency

The value of Return On Tangible Assets is estimated to slide to 0.04. The value of Return On Capital Employed is expected to slide to -0.02. At this time, Tekla Life's Total Current Assets are quite stable compared to the past year. Asset Turnover is expected to rise to 0.06 this year, although the value of Total Assets will most likely fall to about 335.6 M. Tekla Life's management efficiency ratios could be used to measure how well Tekla Life manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 17.25  16.79 
Tangible Book Value Per Share 17.25  16.79 
Enterprise Value Over EBITDA 13.45  14.12 
Price Book Value Ratio 0.96  0.92 
Enterprise Value Multiple 13.45  14.12 
Price Fair Value 0.96  0.92 
Enterprise Value300.7 M233 M
At Tekla Life Sciences, management's focus on innovation and efficiency has led to impressive financial results. We assess these factors to determine the stock's attractiveness to investors.
Dividend Yield
0.145
Operating Margin
(0.32)
Profit Margin
1.5645
Forward Dividend Yield
0.145
Beta
0.705

Technical Drivers

As of the 25th of November, Tekla Life has the Coefficient Of Variation of (1,379), risk adjusted performance of (0.05), and Variance of 1.34. Tekla Life technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Tekla Life Sciences standard deviation and value at risk to decide if Tekla Life is priced more or less accurately, providing market reflects its prevalent price of 13.79 per share. Given that Tekla Life Sciences has information ratio of (0.19), we advise you to double-check Tekla Life Sciences's current market performance to make sure the company can sustain itself at a future point.

Tekla Life Sciences Price Movement Analysis

Execute Study
The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Tekla Life middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Tekla Life Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Tekla Life Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tekla Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tekla Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tekla Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Tekla Life Outstanding Bonds

Tekla Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Tekla Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Tekla bonds can be classified according to their maturity, which is the date when Tekla Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Tekla Life Predictive Daily Indicators

Tekla Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Tekla Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Tekla Life Corporate Filings

3rd of September 2024
Other Reports
ViewVerify
28th of August 2024
Other Reports
ViewVerify
F4
27th of August 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
15th of August 2024
Other Reports
ViewVerify
F4
18th of July 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
27th of June 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
25th of June 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F3
18th of June 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify

Tekla Life Forecast Models

Tekla Life's time-series forecasting models are one of many Tekla Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tekla Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Tekla Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Tekla Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tekla shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tekla Life. By using and applying Tekla Stock analysis, traders can create a robust methodology for identifying Tekla entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 1.09  1.04 
Operating Profit Margin(0.20)(0.21)
Net Profit Margin 1.09  1.04 
Gross Profit Margin 0.70  0.73 

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Tekla Life to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Balance Of Power Now

   

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Module
When determining whether Tekla Life Sciences is a strong investment it is important to analyze Tekla Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tekla Life's future performance. For an informed investment choice regarding Tekla Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.425
Dividend Share
1.3
Earnings Share
1.34
Revenue Per Share
0.134
Quarterly Revenue Growth
0.07
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.